Cargando…

Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats

The abnormally high nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activity is a typical characteristic of traumatic brain injury (TBI). Dexmedetomidine (Dex) is a highly selective α-2 adrenergic receptor agonist that inhibits the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Bin, Zhang, Shuncai, Ying, Yanlu, Guo, Xinying, Li, Hengchang, Xu, Lixin, Ruan, Xiangcai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435454/ https://www.ncbi.nlm.nih.gov/pubmed/30232232 http://dx.doi.org/10.1042/BSR20180892

Ejemplares similares

Intranasal Dexmedetomidine as a Sedative Premedication for Patients Undergoing Suspension Laryngoscopy: A Randomized Double-Blind Study
por: Lu, Chengxiang, et al.
Publicado: (2016)

The role of NLRP3 inflammasome for microglial response to peripheral inflammation
por: Garaschuk, Olga
Publicado: (2020)

NLRP3 inflammasome-induced pyroptosis in digestive system tumors
por: Wen, Jiexia, et al.
Publicado: (2023)

Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats
por: Yu, Wenli, et al.
Publicado: (2020)

Role of NLRP3 inflammasomes in monocyte and microglial recruitments in choroidal neovascularization
por: Dieckmann, Blake W., et al.
Publicado: (2023)

Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury
por: Li, Hengchang, et al.
Publicado: (2020)

Low-Dose Intramuscular Dexmedetomidine as Premedication: A Randomized Controlled Trial
por: Sun, Yang, et al.
Publicado: (2014)

Corrigendum to “Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats”
por: Yu, Wenli, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
por: Irrera, Natasha, et al.
Publicado: (2020)

Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021)

Dexmedetomidine inhibits the NF-κB pathway and NLRP3 inflammasome to attenuate papain-induced osteoarthritis in rats
por: Cheng, Fang, et al.
Publicado: (2019)

Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
por: Tejera, Dario, et al.
Publicado: (2019)

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021)

NLRP3 inflammasome-mediated microglial pyroptosis is critically involved in the development of post-cardiac arrest brain injury
por: Chang, Yuan, et al.
Publicado: (2020)

Hyperbaric oxygen alleviates the activation of NLRP-3-inflammasomes in traumatic brain injury
por: Qian, Huihui, et al.
Publicado: (2017)

The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
por: Ismael, Saifudeen, et al.
Publicado: (2020)

Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease
por: Zhou, Xiao-Gang, et al.
Publicado: (2022)

Microglial exosomes alleviate intermittent hypoxia-induced cognitive deficits by suppressing NLRP3 inflammasome
por: Zhang, Yaodan, et al.
Publicado: (2023)

Dexmedetomidine Alleviates Hypoxia-Induced Synaptic Loss and Cognitive Impairment via Inhibition of Microglial NOX2 Activation in the Hippocampus of Neonatal Rats
por: Chen, Xiaohui, et al.
Publicado: (2021)

The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury
por: Lee, Stephanie W., et al.
Publicado: (2019)

Downregulation of phosphoglycerate mutase 5 improves microglial inflammasome activation after traumatic brain injury
por: Chen, Yuhua, et al.
Publicado: (2021)

Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury
por: Irrera, Natasha, et al.
Publicado: (2017)

The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
por: O’Brien, William T., et al.
Publicado: (2020)

Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy
por: Han, Xiaojuan, et al.
Publicado: (2021)

Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022)

PHLDA1 modulates microglial response and NLRP3 inflammasome signaling following experimental subarachnoid hemorrhage
por: Lai, Jinqing, et al.
Publicado: (2023)

Hyperammonemia induces microglial NLRP3 inflammasome activation via mitochondrial oxidative stress in hepatic encephalopathy
por: Cheon, So Yeong, et al.
Publicado: (2023)

Low-dose dexmedetomidine as a perineural adjuvant for postoperative analgesia: a randomized controlled trial
por: Liu, Wei, et al.
Publicado: (2022)

Neuroprotective Effect of Dexmedetomidine against Postoperative Cognitive Decline via NLRP3 Inflammasome Signaling Pathway
por: Cho, Inja, et al.
Publicado: (2022)

The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
por: Shen, Yao, et al.
Publicado: (2022)

Vav1 promotes inflammation and neuronal apoptosis in cerebral ischemia/reperfusion injury by upregulating microglial and NLRP3 inflammasome activation
por: Qiu, Jing, et al.
Publicado: (2023)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

The Anti-diabetic Drug Gliquidone Modulates Lipopolysaccharide-Mediated Microglial Neuroinflammatory Responses by Inhibiting the NLRP3 Inflammasome
por: Kim, Jieun, et al.
Publicado: (2021)

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
por: Li, Yunna, et al.
Publicado: (2021)

Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells
por: Panda, Chinmaya, et al.
Publicado: (2021)

Corrigendum: Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
Publicado: (2022)

Nonessential Role for the NLRP1 Inflammasome Complex in a Murine Model of Traumatic Brain Injury
por: Brickler, Thomas, et al.
Publicado: (2016)

NEK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury
por: Chen, Yuhua, et al.
Publicado: (2019)

Dexmedetomidine alleviates blunt chest trauma and hemorrhagic shock-resuscitation-induced acute lung injury through inhibiting the NLRP3 inflammasome
por: Ming, Tingqian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7om1c4snkjk5t1p6g8aa3suhso